Search

everythinglearnresearchcommunity

for

Search:↓

Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Natural ingredients can improve skin and hair, but more research is needed.

PRP treatment lacks strong evidence for routine use due to poor study quality.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Case reports are crucial for identifying new medical conditions and improving knowledge retention.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Sublingual minoxidil significantly improves hair growth in transgender individuals on testosterone therapy.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Combining different treatments may be needed to effectively manage chronic prostatitis.

Both treatments for alopecia areata showed similar modest effectiveness.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

1% minoxidil didn't improve hair growth for severe alopecia areata.